HRS-5817

N/A

Report date: 2026/03/30 16:10:51
NME

Base Information

Drug NameHRS-5817
Drug Alias NameHRS-5817HRS5817
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Tuojie Biomedical Technology Co LtdFujian Suncadia Medicine Co LtdJiangsu Hengrui Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Tuojie Biomedical Technology Co LtdAtridia Pty LtdFujian Suncadia Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A